{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:01:39Z","timestamp":1767826899097,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"SFO epidemiology Young Scholar Grant (Karolinska Institutet)"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["839-2008-7496"],"award-info":[{"award-number":["839-2008-7496"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["2015\/460"],"award-info":[{"award-number":["2015\/460"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.canep.2018.04.004","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T18:54:16Z","timestamp":1523300056000},"page":"139-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["PPI use and oesophageal cancer: What if the results are true?"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0137-447X","authenticated-orcid":false,"given":"Nele","family":"Brusselaers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Engstrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Lagergren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2018.04.004_bib0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canep.2018.02.004","article-title":"Maintenance proton pump inhibition therapy and risk of oesophageal cancer","volume":"53","author":"Brusselaers","year":"2018","journal-title":"Cancer Epidemiol."},{"issue":"10","key":"10.1016\/j.canep.2018.04.004_bib0010","doi-asserted-by":"crossref","first-page":"e017739","DOI":"10.1136\/bmjopen-2017-017739","article-title":"Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden","volume":"7","author":"Brusselaers","year":"2017","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.canep.2018.04.004_bib0015","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3322\/caac.21185","article-title":"Recent developments in esophageal adenocarcinoma","volume":"63","author":"Lagergren","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.canep.2018.04.004_bib0020","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/CCM.0000000000001872","article-title":"Stress ulcer prophylaxis","volume":"44","author":"Barletta","year":"2016","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.canep.2018.04.004_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of helicobacter pylori infection-the Maastricht V\/Florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"issue":"6\u20137","key":"10.1016\/j.canep.2018.04.004_bib0030","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/00365521.2017.1303844","article-title":"Helicobacter pylori eradication in the Swedish population","volume":"52","author":"Doorakkers","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.canep.2018.04.004_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-5573-1-3","article-title":"The missed lessons of Sir Austin Bradford Hill","volume":"1","author":"Phillips","year":"2004","journal-title":"Epidemiol. Perspect. Innov."},{"key":"10.1016\/j.canep.2018.04.004_bib0040","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.canep.2018.04.004_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2017-315710","article-title":"Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for helicobacter pylori: a retrospective cohort analysis","author":"Niikura","year":"2017","journal-title":"Gut"},{"issue":"Jan. (1)","key":"10.1016\/j.canep.2018.04.004_bib0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for helicobacter pylori: a population-based study","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"},{"issue":"Dec. (1)","key":"10.1016\/j.canep.2018.04.004_bib0055","first-page":"199","article-title":"Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man","volume":"67","author":"Waldum","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.canep.2018.04.004_bib0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canep.2016.12.006","article-title":"Proton pump inhibitors on pancreatic cancer risk and survival","volume":"46","author":"Kearns","year":"2017","journal-title":"Cancer Epidemiol."},{"issue":"5","key":"10.1016\/j.canep.2018.04.004_bib0065","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4082\/kjfm.2012.33.5.272","article-title":"Use of proton pump inhibitor and risk of colorectal cancer: a meta-analysis of observational studies","volume":"33","author":"Ahn","year":"2012","journal-title":"Korean J. Fam. Med."},{"issue":"4","key":"10.1016\/j.canep.2018.04.004_bib0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/19490976.2017.1284732","article-title":"The influence of proton pump inhibitors and other commonly used medication on the gut microbiota","volume":"8","author":"Imhann","year":"2017","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.canep.2018.04.004_bib0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.canep.2018.04.004_bib0080","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.canep.2018.04.004_bib0085","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/apt.14451","article-title":"Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications","volume":"47","author":"Le Bastard","year":"2018","journal-title":"Aliment Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.canep.2018.04.004_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11938-017-0115-5","article-title":"Clinical implications of emerging data on the safety of proton pump inhibitors","volume":"15","author":"Schnoll-Sussman","year":"2017","journal-title":"Curr. Treat. Options Gastroenterol."},{"issue":"5","key":"10.1016\/j.canep.2018.04.004_bib0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrgastro.2016.44","article-title":"Therapy: risks associated with chronic PPI use \u2013 signal or noise?","volume":"13","author":"Kia","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Suppl. 1","key":"10.1016\/j.canep.2018.04.004_bib0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000199381","article-title":"Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion","volume":"35","author":"Havu","year":"1986","journal-title":"Digestion"},{"issue":"12","key":"10.1016\/j.canep.2018.04.004_bib0105","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/gut.26.12.1284","article-title":"Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat","volume":"26","author":"Poynter","year":"1985","journal-title":"Gut"},{"key":"10.1016\/j.canep.2018.04.004_bib0110","first-page":"53","article-title":"Toxicological studies on omeprazole","volume":"108","author":"Ekman","year":"1985","journal-title":"Scand. J. Gastroenterol. Suppl."},{"issue":"7","key":"10.1016\/j.canep.2018.04.004_bib0115","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/00365521.2016.1143527","article-title":"Does long-term profound inhibition of gastric acid secretion increase the risk of ECL cell-derived tumors in man?","volume":"51","author":"Waldum","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.canep.2018.04.004_bib0120","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3748\/wjg.14.1646","article-title":"Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia","volume":"14","author":"Fossmark","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"Apr. (4)","key":"10.1016\/j.canep.2018.04.004_bib0125","first-page":"672","article-title":"Long-term use of antibiotics and risk of colorectal adenoma","volume":"67","author":"Cao","year":"2018","journal-title":"Gut"},{"issue":"Mar. (2)","key":"10.1016\/j.canep.2018.04.004_bib0130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12282-016-0734-z","article-title":"Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications","volume":"24","author":"Yang","year":"2017","journal-title":"Breast Cancer"},{"issue":"8","key":"10.1016\/j.canep.2018.04.004_bib0135","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1023\/A:1026323424792","article-title":"Hypothesis: is antibiotic use associated with breast cancer?","volume":"14","author":"Velicer","year":"2003","journal-title":"Cancer Cause Control"},{"issue":"1","key":"10.1016\/j.canep.2018.04.004_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2036.2000.00681.x","article-title":"Personal review: is profound acid inhibition safe?","volume":"14","author":"Waldum","year":"2000","journal-title":"Aliment Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.canep.2018.04.004_bib0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1517\/14740338.1.1.29","article-title":"Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections","volume":"1","author":"Waldum","year":"2002","journal-title":"Expert Opin. Drug Saf."},{"issue":"6","key":"10.1016\/j.canep.2018.04.004_bib0150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2036.1993.tb00139.x","article-title":"Review article: the use of gastric acid-inhibitory drugs\u2013physiological and pathophysiological considerations","volume":"7","author":"Waldum","year":"1993","journal-title":"Aliment Pharmacol. Ther."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118301012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118301012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T11:52:52Z","timestamp":1534938772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782118301012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":30,"alternative-id":["S1877782118301012"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2018.04.004","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPI use and oesophageal cancer: What if the results are true?","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2018.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}